In individual PHTS patients exhibiting clinical phenotypes, PTEN germline mutations are reported in 25-85% of CS patients [21,25,26], 60% of BRRS [21,22,25,27], up to 20% of PS [28], and between 50 and 67% of PS-like syndrome patients [24]. This evidence concerns the gene PTEN and PTEN hamartoma tumor syndrome.